Viatris
VTRS
#1390
Rank
โ‚น1.503 T
Marketcap
โ‚น1,291
Share price
2.67%
Change (1 day)
101.70%
Change (1 year)

Revenue for Viatris (VTRS)

Revenue in 2025 (TTM): โ‚น1.251 Trillion

According to Viatris's latest financial reports the company's current revenue (TTM ) is โ‚น1.335 Trillion. an increase over the revenue in the year 2024 that were of โ‚น1.264 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viatris from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น1.283 T1.52%
2024 โ‚น1.264 T-1.54%
2023 โ‚น1.284 T-4.57%
2022 โ‚น1.345 T1.08%
2021 โ‚น1.331 T52.38%
2020 โ‚น873.65 B6.53%
2019 โ‚น820.11 B2.58%
2018 โ‚น799.48 B5.15%
2017 โ‚น760.31 B1.01%
2016 โ‚น752.72 B20.12%
2015 โ‚น626.62 B28.08%
2014 โ‚น489.25 B14.62%
2013 โ‚น426.84 B15.06%
2012 โ‚น370.98 B14.41%
2011 โ‚น324.26 B32.77%
2010 โ‚น244.23 B3.36%
2009 โ‚น236.30 B-4.31%
2008 โ‚น246.93 B
2006 โ‚น67.51 B20.12%
2005 โ‚น56.20 B2.17%
2004 โ‚น55.01 B-13.38%
2003 โ‚น63.51 B10.54%
2002 โ‚น57.45 B11.27%
2001 โ‚น51.63 B36.13%
2000 โ‚น37.92 B13.89%
1999 โ‚น33.30 B17.54%
1998 โ‚น28.33 B40.99%
1997 โ‚น20.09 B34.32%
1996 โ‚น14.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น59.94 B-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.1 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA